Insights › Energy & climate › November 18, 2026
Energy & climate · Pipeline & development

New Treatment Strategy for Down Syndrome Shows Promise in Phase 2 Clinical Trial

PR Newswire (Clinical Trials) Published: Trial

Phase 2 clinical trial published in Cell Reports Medicine finds JAK inhibitor safely reduces immune overactivity, improves inflammatory skin conditions and opens new avenues for research on brain health and Alzheimer's disease The takeaway: Researchers at the Linda Crnic Institute for...

Original source
Read the source — prnewswire.com ↗

We link to the original publisher. The summary above is a short guide; read the original for the full details.

More in Energy & climate

See everything in Energy & climate →

Look into this further

Read every record in your own language

This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.

Read it all — start from $3No app-store installation. Cancel any time.